NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDCytarabine  Malignant disease and immunosuppression, Antimetabolites, 08.01.03
REDCytarabine - Daunorubicin (liposomal) Vyxeos®
(Infusion) 		Malignant disease and immunosuppression, Anthracyclines and other cytotoxic antibiotics, 08.01.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Cytarabine Cytarabine [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Antimetabolites
Cytotoxic Responsive Malignancy
Daunorubicin Daunorubicin With Cytarabine [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Anthracyclines And Related Drugs
Cytotoxic Responsive Malignancy
Daunorubicin Daunorubicin With Cytarabine [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Antimetabolites
Cytotoxic Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA552: Liposomal cytarabine–daunorubicin for untreated acute myeloid leukaemia
NICE TA787 Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
NICE TA787: Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable